Text Size
82 studies found for:    "Expanded Access" [STUDY-TYPES] | Open Studies

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Available Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Sirolimus;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Drug: Mycophenolic acid
22 Unknown † Efficacy and Safety Study of Neoadjuvant Chemotherapy for Local Advanced Triple Negative Breast Cancer Patients
Condition: Triple Negative Local Advanced Breast Cancer
Intervention: Drug: docetaxel oxaliplatin
23 Available Treatment of Lambert-Eaton Syndrome With 3,4 DAP
Condition: Lambert Eaton Myasthenic Syndrome
Intervention: Drug: 3, 4 DAP
24 Available Mentor Siltex® Contour Profile Gel Mammary Prosthesis Continued Access Clinical Trial
Conditions: Breast Augmentation;   Breast Reconstruction;   Breast Revision
Intervention: Device: Mentor Siltex® Contour Profile Gel Mammary Prosthesis
25 Available Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Pomalidomide
26 Available An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection
Condition: HIV Infection
Intervention: Drug: Efavirenz
27 Unknown † Clinical Research on the Efficacy of Acupuncture Treatment in Chronic Low Back Pain
Conditions: Chronic Low Back Pain;   Acupuncture
Intervention: Device: Acupuncture, Pak-sham needle
28 Available 131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol
Condition: Neuroblastoma
Intervention: Drug: Metaiodobenzylguanidine (MIBG)
29 Unknown † Hypercalciuria and Calcium Stone Disease in Caucasian Patients
Conditions: Hypercalciuria;   Calcium Stone Disease
Interventions: Radiation: Radiological testing;   Genetic: Pediatric Urologic DNA and History Repository
30 Available Weight-bearing Measuring Device to Determine Normative Percentage Body-Weight/Weight-Bearing Values and Weight-bearing Gait Characteristics
Conditions: Percentage Body-Weight;   Weight-Bearing Values;   Weight-bearing Gait Characteristics
Intervention: Device: SmartStep insole
31 Available Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma
Conditions: Pheochromocytoma;   Paraganglioma
Intervention: Drug: 131 I-Metaiodobenzylguanidine (131 I-MIBG)
32 Available Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver Disease
Conditions: Cholestasis;   Short Bowel Syndrome
Intervention: Drug: Omegaven
33 Available Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome
Condition: Lambert-Eaton Myasthenic Syndrome
Intervention: Drug: 3,4 DAP
34 Available Dextromethorphan Added on for the Patients With ADHD
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Dextromethorphan
35 Available Compassionate Use of 3,4-Diaminopyridine
Conditions: Lambert Eaton Myasthenic Syndrome (LEMS);   Myasthenic Syndromes, Congenital
Intervention: Drug: 3,4-diaminopyridine
36 Unknown † The Randomized Study of Dasatinib and High-Dose Imatinib (600mg) in Suboptimal Responder
Condition: Chronic Myeloid Leukemia
Intervention: Drug: Dasatinib and Imatinib
37 Available Treatment Protocol to Observe the Safety of Agalsidase Alfa in Canadian Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Biological: agalsidase alfa
38 Unknown † Ambulatory Blood Pressure Measurement in Children With Congenital Urine Flow Obstruction
Conditions: Hydronephrosis;   Multicystic-Dysplastic Kidney
Intervention: Device: 24-hour ambulatory blood pressure monitor
39 Available Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment
Condition: Renal Cell Carcinoma
Intervention: Drug: Axitinib
40 Available A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema
Condition: Diabetic Macular Edema
Intervention: Drug: Macugen (Pegaptanib Sodium)
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years